Terms: = Breast cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Staging
4 results:
1. Predictive value of ductal carcinoma in situ with invasive breast cancer in core needle biopsies for final pathologic size of intraductal elements.
Matsumoto H; Ishii A; Nakada N; Koki A; Unesoko M; Abe N; Zaha H
Virchows Arch; 2022 Apr; 480(4):739-748. PubMed ID: 34993592
[TBL] [Abstract] [Full Text] [Related]
2. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract] [Full Text] [Related]
3. A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study.
Qin W; Wang L; Hu B; Leng S; Tian H; Luo H; Yao J; Chen X; Wu C; Chen G; Yang Y
J Gastrointest Surg; 2019 May; 23(5):922-932. PubMed ID: 30446938
[TBL] [Abstract] [Full Text] [Related]
4. Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Angelini G; Marini C; Iacconi C; Mazzotta D; Moretti M; Picano E; Morganti R
Clin Imaging; 2018; 49():12-16. PubMed ID: 29120811
[TBL] [Abstract] [Full Text] [Related]
